ODTX
Odyssey Therapeutics, Inc.
20.40$
-8.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | |
| – | – | – | 100.0% | |
| – | 10,827.3% | 2,517.4% | 4,254.6% | |
| – | 2,140.5% | 606.4% | 1,260.6% | |
| – | 12,967.8% | 3,123.8% | 5,515.2% | |
| – | -12,867.8% | -3,023.8% | -5,415.2% | |
| – | 32.3% | 0.4% | 0.6% | |
| – | -12,101.4% | -2,881.3% | -5,026.0% | |
| – | – | – | -31.1% | |
| – | -12,144.5% | -2,891.8% | -4,994.9% | |
| – | -11,595.8% | -2,764.8% | -4,860.4% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.